Optimark and Hyperthyroidism aggravated - a phase IV clinical study of FDA data

Summary:

Hyperthyroidism aggravated is reported only by a few people who take Optimark.

The study analyzes which people take Optimark and have Hyperthyroidism aggravated. It is created by eHealthMe based on reports of 3,054 people who have side effects while taking Optimark from the FDA, and is updated regularly.

What is Optimark?

Optimark has active ingredients of gadoversetamide. eHealthMe is studying from 3,055 Optimark users. Check the latest studies of Optimark.

What is Hyperthyroidism aggravated?

Hyperthyroidism aggravated (over activity of the thyroid gland) is found to be associated with 882 drugs and 361 conditions by eHealthMe. Check the latest studies of Hyperthyroidism aggravated.

On Jun, 22, 2026

3,054 people reported to have side effects when taking Optimark.
Among them, 4 people (0.13%) have Hyperthyroidism aggravated.

Could Optimark cause Hyperthyroidism aggravated?

Among these 4 people:

How long have people been on Optimark when they have Hyperthyroidism aggravated? *

What is the gender of people who have Hyperthyroidism aggravated when taking Optimark? *

female: 0.0 %
male: 100 %

What is the age of people who have Hyperthyroidism aggravated when taking Optimark? *

What are other drugs people take besides Optimark? *

What are other side effects people have besides Hyperthyroidism aggravated? *

Anaemia (lack of blood): 4 people, 100.00%
Fibromyalgia (a long-term condition which causes pain all over the body): 4 people, 100.00%
Superior Vena Caval Occlusion (obstruction of blood flow through the superior vena cava): 4 people, 100.00%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 4 people, 100.00%
Nephrogenic Systemic Fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease): 4 people, 100.00%
Lacunar Infarction (a type of stroke): 4 people, 100.00%
Intervertebral Disc Degeneration (spinal disc degeneration): 4 people, 100.00%
Arthritis Bacterial (form of joint disorder that involves inflammation of one or more joints due to bacterial infection): 3 people, 75.00%
Back Pain: 3 people, 75.00%
Cerebral Ischaemia (insufficient blood flow to the brain to meet metabolic demand): 3 people, 75.00%

What are the existing conditions these people have? *

Nuclear Magnetic Resonance Imaging Brain: 4 people, 100.00%
Musculoskeletal Pain (pain affects the bones, muscles, ligaments, tendons, and nerves): 4 people, 100.00%
Impaired Gastric Emptying: 4 people, 100.00%
Gastritis (inflammation of stomach): 4 people, 100.00%
Diabetes: 4 people, 100.00%
Bacterial Infection: 4 people, 100.00%
Joint Pain: 1 person, 25.00%

* Approximation only. Some reports may have incomplete information.

Do you take Optimark and have Hyperthyroidism aggravated?

- Check whether Hyperthyroidism aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Optimark:

Optimark (3,055 reports)

Browse all side effects of Optimark:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hyperthyroidism aggravated:

Hyperthyroidism aggravated (882 drugs)

Browse all the conditions that are associated with Hyperthyroidism aggravated:

Hyperthyroidism aggravated (361 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on gadoversetamide (the active ingredients of Optimark) and Optimark (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.